Alder BioPharmaceuticals, Inc. Operating Income 2014-2019 | ALDR
Alder BioPharmaceuticals, Inc. operating income from 2014 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Alder BioPharmaceuticals, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2018 | $-287 |
| 2017 | $-291 |
| 2016 | $-158 |
| 2015 | $-86 |
| 2014 | $9 |
| 2013 | $-21 |
| 2012 | $-18 |
| Alder BioPharmaceuticals, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2019-06-30 | $-56 |
| 2019-03-31 | $-114 |
| 2018-12-31 | $-78 |
| 2018-09-30 | $-58 |
| 2018-06-30 | $-65 |
| 2018-03-31 | $-86 |
| 2017-12-31 | $-55 |
| 2017-09-30 | $-60 |
| 2017-06-30 | $-75 |
| 2017-03-31 | $-101 |
| 2016-12-31 | $-49 |
| 2016-09-30 | $-36 |
| 2016-06-30 | $-39 |
| 2016-03-31 | $-34 |
| 2015-12-31 | $-26 |
| 2015-09-30 | $-27 |
| 2015-06-30 | $-18 |
| 2015-03-31 | $-15 |
| 2014-12-31 | $-7 |
| 2014-09-30 | $29 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-5 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-6 |
